Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

Pace Analytical® Expands CDMO Capabilities with Bio-Concept Laboratories Acquisition


Pace Analytical Acquisition

We have the ability to accelerate product development by shifting programs between sites, based on areas of specialty and expertise.

Pace Analytical Life Sciences, LLC, a subsidiary of Pace Analytical® Services, LLC, a full-service contract development and manufacturing organization (CDMO), today announced that it has acquired Bio-Concept Laboratories, Inc., a pharmaceutical CDMO specializing in formulation development and fill-finish manufacturing of sterile aqueous products.

“Pace clients have been asking us to add sterile materials for clinical trials to our CDMO capabilities,” said Eric Roman, Pace Analytical CEO. “Bringing Bio-Concept Laboratories onboard allows us to respond to that demand while increasing our capacity to service the market throughout the drug delivery life cycle – from formulation research and development to pre-clinical and clinical trial materials.”

As a result of its sterile materials production capabilities, Bio-Concept Laboratories has gained significant experience in ophthalmic formulation and manufacturing to support phase I, II, and III clinical trial materials. “Adding Bio-Concept to the Pace Life Sciences lab network provides more leverage in our operations,” notes Pace Life Sciences COO, Greg Kupp. “We have the ability to accelerate product development by shifting programs between sites, based on areas of specialty and expertise. This is a significant advantage to clients requiring agility and flexibility and for those relying on Pace to manage programs from development to phase I, II, and III clinical trial material production.”

Bio-Concept Laboratories president and CEO, Francis X. Smith, will remain with the company through the transition process. Of the transaction, Smith comments, “Bio-Concept and Pace have strong alignment in our customer-first mentality. As a result of this transaction, our customers will have the benefit of greater resources and increased capacity to serve more of their needs.” Frank Tagliaferri, Pace Vice President of Pharmaceutical Development, will oversee the operations of the Bio-Concept Laboratories.

Over the upcoming months, Bio-Concept Laboratories will transition to operating under the Pace Analytical® Services brand. Bio-Concept is located in Salem, New Hampshire, further strengthening the presence of Pace Life Sciences lab locations in the New England area.

About Bio-Concept Laboratories

Bio-Concept Laboratories, Inc. is a CDMO operating in the pharmaceutical field that offers new product development services including formulation development and fill-finish manufacturing of aseptic aqueous products for toxicology studies, clinical trial research, and commercial manufacturing. Its experience encompasses dosage forms for topical ophthalmics, intravitreal drug delivery to the eye and parenteral administration. Bio-Concept services are rendered in its own 30,000 square foot facility in Salem New Hampshire. Learn more at http://www.bioconcept.com.

About Pace Analytical® Life Sciences

Pace Analytical Life Sciences, LLC. is a network of full-service contract CMC development and GMP analytical testing laboratories. CMC development, chemistry, and microbiology central lab testing services are provided to the pharmaceutical, biopharmaceutical, and gene therapy manufacturing industries. Our investment in state-of-the-art facilities and highly-trained experts emphasizes our commitment to delivering positive customer experiences across all channels of our business. We are dedicated to providing not only the best in analytical testing services but the most reliable. A subsidiary of Pace Analytical® Services, LLC, Pace Analytical Life Sciences operates FDA-registered laboratory testing facilities in Oakdale, Minnesota, San German, Puerto Rico, and CDMO facilities in Woburn, Massachusetts, and Philadelphia, PA. Learn more at PACELABS.com

About Pace Analytical® Services

Pace Analytical® Services, LLC makes the world a safer, healthier place. For decades, we have been the trusted source for quality life sciences and environmental lab testing and analysis and the resource for scientific lab staffing, regulatory, and equipment services. Our work is done in partnership with our clients by providing the science and the data they need to make critical decisions that benefit us all. Pace delivers science better to businesses, industries, consulting firms, government agencies, and more through the largest, American-owned and nationally certified laboratory network. Science matters at PACELABS.com

Share article on social media or email:

Target ALS Launches The First-Ever Comprehensive Research Initiative to Discover Urgently Needed ALS Biomarkers


Target ALS Launches The First-Ever Comprehensive Research Initiative to Discover Urgently Needed ALS Biomarkers

This is a major milestone for Target ALS, as we’ve proven our ability to respond to the needs of the scientific community in ways that accelerate their work like never before.

Today, Target ALS launched the first-ever comprehensive effort to discover ALS biomarkers — The Target ALS Diagnosis Initiative — through which the organization will invest $15 million in collaborative grantmaking and the development of new scientific resources. The initiative was developed in response to input from over 100 scientists, patients, caregivers and other thought leaders. They universally identified ALS biomarkers as a critical unmet need to diagnose the disease early, track its progression and provide reliable measures for new treatments.

“This is a major milestone for Target ALS, as we’ve proven our ability to respond to the needs of the scientific community in ways that accelerate their work like never before. We are now increasing this commitment significantly, with The Target ALS Diagnosis Initiative, in order to advance ALS biomarker research,” said Target ALS Chief Executive Officer, Manish Raisinghani, MBBS, Ph.D. “It’s been gratifying for our team to support scientists over the last seven years and know that we are spearheading access to essential resources that can help them realize life-changing benefits for people with ALS.”

The Target ALS Diagnosis Initiative strategically focuses on three promising areas:

  • Establishing new ALS biomarker-focused collaborative funding opportunities to fuel new projects for discovery and development of ALS biomarkers.
  • Creating a five-year natural history study that will integrate longitudinal biofluid collection, clinical-grade speech, language and respiratory measures, clinical and demographic information, as well as genomic datasets from ALS and control cases.
  • Developing an integrated Biofluid and Genomics core that will exponentially improve the impact of human biosamples on research through the integration of longitudinal biofluids, genomic datasets and postmortem tissue with expedited, no-strings-attached access to samples worldwide.

THE TARGET ALS DIAGNOSIS INITIATIVE IN-DEPTH

Components of The Target ALS Diagnosis Initiative, with more to be added potentially in the future based on research needs and opportunity, are as follows:

COLLABORATIVE FUNDING FOR ALS BIOMARKER RESEARCH

Target ALS is building on its collaborative grantmaking efforts to support new ALS biomarker discovery and development projects. It will include both pre-competitive funding, where a panel of experts openly formulate projects by consensus with results shared immediately with the research community, and competitive funding, to encourage ideas from investigators and advance the most promising collaborations.

Pre-competitive research: A working group of over 30 representatives from pharmaceutical, academic and non-profit foundations will collaborate on new, innovative approaches for the discovery, validation and development of novel ALS biomarker candidates. This effort will build upon work initiated in 2017, through which Target ALS funded four ALS biomarker projects as recommended by the working group: Phosphorylated neurofilament; heavy and light chains (in partnership with the Muscular Dystrophy Association); Urinary p75 neurotrophin receptor extracellular domain (in partnership with the Muscular Dystrophy Association); and TDP-43 (in partnership with The ALS Association).

Competitive research: Later this month, Target ALS will announce the results of the first-ever request for proposals focused on ALS biomarker discovery and development that required academic investigators and the pharma/biotech industry to collaborate in order to receive funding. This builds on a $5 million funding call, issued last fall with The Association for Frontotemporal Degeneration, targeting treatments and biomarkers for ALS and FTD.

NATURAL HISTORY STUDY

Expedited no-strings-attached access to longitudinal biofluid samples has been a long-standing barrier for most researchers. These samples are invaluable in the search for ALS biomarkers and drug targets as they are donated by living patients over the course of their disease, thereby offering unique insights into the pathogenic evolution of the disease over time.

Target ALS will launch a five-year natural history study that will aim to integrate collection of biofluids — including CSF, blood and urine along with clinical speech, language and respiratory measures, and demographic information from over 200 ALS and 80 non-disease patients.

Speech and language collection and analysis will be provided by speech neuroscience innovators, Aural Analytics, Inc. They will help bolster the collection of vital biomarker information, drawing upon their expertise in gathering rich, interpretable and validated data on neurological and respiratory health.

In line with the Target ALS mandate, biofluid samples and datasets of the natural history study will be shared with the research community worldwide expeditiously with no strings attached.

INTEGRATED BIOSAMPLES AND GENOMICS CORE

Target ALS already provides ALS researchers worldwide with unprecedented access to critically needed research tools and resources, with no strings attached, through six scientific core facilities: Human Postmortem Tissue, Human Genomic Datasets, Human-Derived Stem Cells, Animal Models, Antibodies and Viral Vectors.

Target ALS is now extending these resources with a first-of-its-kind integrated Biosamples and Genomics core. This new core expands the impact of biosamples and data accessible through the Postmortem Tissue and Genomics cores by linking them to longitudinal collection of biofluid samples from ALS and control cases that will be carried out as part of the natural history study. As with all of the core resources created by Target ALS, the Biosamples and Genomics core will be accessible to researchers worldwide.

Although collection of longitudinal biofluids and postmortem tissue, as well as generation of and genomic datasets, as occurred in the past, unlike the Target ALS effort, they were implemented largely as standalone projects, therefore limiting their impact.

The new Integrated Biosamples and Genomics core is made possible through existing alliances with the ALS Association, the Tow Foundation and the New York Genome Center as well as the new partnership with Aural Analytics. Together, the partnership forms a triadic structure, aiming to offer a more complete picture of the pathogenesis of ALS as provided through patient biofluids — including CSF, blood and urine — as the disease progresses (longitudinal biofluid samples), after death (postmortem tissue) and the genomic, clinical and demographic datasets associated with these samples.

ABOUT TARGET ALS

Target ALS is a 501(c)(3) medical research foundation committed to the search for effective treatments for Amyotrophic Lateral Sclerosis (ALS), also known as Lou Gehrig’s disease. We envision a world in which no one dies of ALS and play a unique role in the battle against this disease. Founded in 2013 by former New York City deputy mayor Dan Doctoroff – who lost both his father and uncle to ALS – our approach is breaking down barriers and silos that previously inhibited research results. We do this through our Target ALS Innovation Ecosystem, which facilitates unparalleled collaboration between researchers from academia and the pharma/biotech industry. The Target ALS Innovation Ecosystem has revolutionized the field in just seven years through collaborations that have resulted in the first potential treatments since ALS was identified in 1869.

To date, the Target ALS Innovation Ecosystem, which launched in 2013 and set the groundwork for the new Target ALS Diagnosis Initiative, has yielded 175+ research projects, 12+ therapeutic targets and five clinical trials, to date.

###

Contact: Steve Schonberg

Director of Communications

steve.schonberg@targetALS.org

(917) 717-0207

The Dentists at The Dental Studio of Midland Offer Life-Changing Oral Health Care in Midland, TX


Dr. Tye Thompson, Dentist in Midland, TX

Dr. Tye Thompson Offers Life-Changing Oral Health Care in Midland, TX

The highly experienced dentists at The Dental Studio of Midland offer a full suite of advanced dental care to help keep their patients in prime oral health.

The Dental Studio of Midland raises awareness of the connection between oral health and overall health, encouraging its community to receive the oral health care they need in order to maintain strong immune systems and whole-body health. These compassionate and experienced dentists offer leading dental care with sedation dentistry in Midland, TX, including tooth extractions, laser dentistry for gum disease, and permanent dental implants.

When a mouth suffers from disease and decay, it can lead to oral concerns, such as tooth loss, and systemic concerns such as diabetes or heart disease, and can even result in preeclampsia or preterm labor in pregnancy. Recent research from the American Dental Association (ADA) reports that a majority of dentists are seeing an increase in stress-induced oral concerns since the onset of the coronavirus pandemic, including gum disease, teeth grinding, cavities, and chipped or cracked teeth. Because the mind, mouth, and body are so interconnected, the dentists at The Dental Studio of Midland are urging the community of Midland, TX to seek treatment at the first sign of symptoms related to a decline in oral health.

The highly experienced dentists at The Dental Studio of Midland offer a full suite of advanced dental care to help keep their patients in prime oral health. For those experiencing tender, swollen, or bleeding gums, the doctors can provide a variety of gum disease treatments, including minimally invasive laser dentistry. Additionally, they treat peri-implantitis, or gum disease that has infected dental implants. For those missing teeth, these dentists are trained and experienced in providing life-changing dental implants. With dental implants, those with missing teeth are able to restore both the beauty and function of their smiles.

The team at The Dental Studio of Midland understands the anxiety that might arise about getting care during the coronavirus pandemic. They are strictly adhering to the guidelines recommended by the CDC, OSHA, and ADA, as well as limiting the number of patients in the office at a time and implementing thorough sanitization protocols. For those who are still experiencing dental fear or pandemic-related anxiety, the doctors offer a variety of sedation dentistry options for every treatment.

Individuals looking to improve their oral health in Midland, TX in order to maintain a healthy immune system and keep their whole-body health in peak condition, can connect with the dentists at The Dental Studio of Midland for a consultation. To schedule an appointment, call 432-687-0629 or visit http://www.midlanddentalstudio.com.

About the Dentists

The Dental Studio of Midland offers comprehensive and caring dental care to patients in Midland, TX. Committed to serving custom care that patients truly need, Drs. Tye Thompson, Jordon Green, and Mallory Gonzales build relationships with each patient in order to understand their unique needs and goals. Both Drs. Thompson and Green completed dental training at the prestigious University of the Pacific and continue to expand their knowledge in dentistry by attending multiple continuing education courses. Dr. Gonzales brings her experience from the University of Texas to the team. The Dental Studio of Midland is equipped with advanced dental technology to provide patients with the highest standard of care. Drs. Thompson, Green, and Gonzales all bring their unique art and “niche” to The Dental Studio of Midland. Some of the services offered are laser dentistry, Invisalign®, full mouth reconstruction, and sedation dentistry. The Dental Studio of Midland team is dedicated to providing the most efficient, least painful procedures for patients, and offer minimally invasive surgery whenever possible. To learn more about Drs. Thompson, Green, and Gonzales and the services offered at The Dental Studio of Midland, call 432-687-0629 or visit http://www.midlanddentalstudio.com.

Share article on social media or email:

Dentist, Dr. Robert Leedy, Celebrates 35 Years Providing Dental Care in Abilene, TX


Dr. Robert Leedy, Dentist in Abilene, TX

Dentist, Dr. Robert Leedy, Provides Dental Care in Abilene, TX for 35 Years

Dr. Leedy can always be counted on to provide the most innovative and advanced treatments at his practice.

Dr. Robert Leedy, an experienced and passionate dentist in Abilene, TX, celebrates his 35th year in practice providing comprehensive general dentistry services and dental implants. Dr. Leedy has grown his dental office, Leedy Dental, since 1985 and now practices with three associates, Dr. Sara Chen, Dr. Albert Park, and Dr. Jaci Campo.

Since 1985, Dr. Leedy has helped countless patients find a renewed quality of life with his personalized dental care. Due to his expertise and dedication, he has become known in the community as the dentist who restores what others cannot fix. He continues to remain passionate about treating patients with dental anxiety and those with complex dental problems, and has specialized in full mouth rehabilitation with dental implants for over 25 years. An active member of the International Congress of Oral Implantologists, Academy of General Dentistry, and American Academy of Cosmetic Dentistry, Dr. Leedy can always be counted on to provide the most innovative and advanced treatments at his practice.

Dr. Leedy is also passionate about providing the highest quality dental care. He has invested in numerous dental technologies and sedation, and has equiped his office with dedicated surgical suites and a sophisticated in-house dental lab. These state-of-the-art advancements improve patient experiences by allowing the team at Leedy Dental to provide more personalized, comfortable, and long-lasting dental care. For full mouth rehabilitation and treatment with dental implants, Dr. Leedy uses precision CBCT scanning and custom surgical guides to help guarantee efficient and predictable surgery. His in-house dental lab allows the team to provide hand-crafted dentures and hybrid arches, delivered the day of surgery for immediate functional and aesthetic benefits.

Leedy Dental has also expanded to provide the full range of comprehensive dental care, including cosmetic dentistry, periodontics, laser dentistry, sedation, and restorative treatments. Along with his associates, Dr. Leedy helps patients of all ages love their smiles again, no matter if they desire cosmetic services or need complex restorative treatment with dental implants. With a legacy of amazing dentistry for the past 35 years, the team at Leedy Dental remains dedicated to providing the same quality of care now and in the future.

Those interested in receiving dental care, including dental implants, from the dentist in Abilene, TX who restores what others cannot fix, or any of his highly skilled staff, are invited to schedule an appointement at Leedy Dental. To contact the practice, visit http://www.leedydental.com or call 325-268-0013.

About the Practice

Leedy Dental is a comprehensive dental practice located in Abilene, TX that specializes in full mouth rehabilitation and implant dentistry, as well as personalized dental care and cosmetic services. Drs. Robert Leedy, Sara Chen, Albert Park, and Jaci Campo, the team of experienced dentists and prosthodontists, are skilled in treating patients with dental phobias and those with severe dental problems. Their state-of-the-art practice is equipped with advanced and innovative technologies, an in-office dental laboratory, sedation services, and dedicated surgical suites for dental implant treatment. The practice founder, Dr. Leedy has over 35 years of experience treating patients with dental conditions that most dentists do not want to fix, helping them achieve life-long health and confidence. Dr. Leedy and his team remain at the forefront of dental care through advanced training and continuing education to provide the most specialized and modern treatments for their patients. To learn more about the life-changing services provided at Leedy Dental, visit http://www.leedydental.com or call the Abilene, TX practice at 325-268-0013.

Share article on social media or email:

2020 Award-Winning New Holiday Gift Soothes Stress, Insomnia, Anxiety, Depression for Deep, Easy Sleep from Relaxintuit.com


Your Present A Half Hour of Peace, 2nd Edition Revised and Expanded by Award-Winning Stress Relief Expert Susie Mantell CD Cover.jpg

Your Present A Half Hour of Peace, 2nd Edition Revised and Expanded by Award-Winning Stress Relief Expert Susie Mantell CD Cover.jpg

“Exquisite…a transformative, powerful collection of meditations…a lullaby for the soul.” – AudioFile Magazine

More Strung-Out Than the Lights on the Tree?

Burning Out Like a Hanukkah Candle?

Stress relief expert Susie Mantell’s exquisite new guided meditation audiobook soothes away layer-after-layer of stress, anxiety, insomnia, loneliness and depression. With a voice described as “velvet,” Your Present: A Half-Hour of Peace, 2nd Edition Revised and Expanded — 3 Soothing Guided Meditations for Deep Stress Relief, Effortless Sleep & Renewed Energy gently carries listeners into deep relaxation and restorative sleep.

Listen Now to Soothing Meditation Sample: https://www.relaxintuit.com/about-stress-cd-sleep-cd-audiobook/

Order on Amazon, iTunes, GooglePlay and Wherever Audiobooks Are Sold: (Available on Digital Download Audiobook and CD Formats.)

Synopsis:

  • “Sleep Easy Now” (Meditation)


Like an easy chair, Susie Mantell’s exquisite narration carries listeners into deep, effortless sleep, soothing worry, insomnia, depression and pain from sleepless nights.

  • “10-Minute Brain Vacation” (Meditation)


Pressed for Time? An oasis from a busy day, slow down, and just let go. Relax, Replenish, Re-Energize — in 10 Minutes Flat!

  • “Your Present: A Half-Hour of Peace” (Meditation, Revised)


With a voice described as “velvet,” this award-winning guided imagery meditation gently relieves isolation and loneliness in uncertain times, easing insomnia and anxiety.

  • BONUS: “30+ Quicktips & Simple Soothers”


Mantell also shares gently empowering stress relief tips and mindfulness techniques to lift spirits, calm day-to-day stress, ease caregiver fatigue, loneliness and offer comfort in eldercare for seniors. “Exquisite…a transformative, powerful collection of meditations… a lullaby for the soul,” raves AudioFile Magazine.

[In Praise of the 1st Edition]

  • “Best Audios Award” – Publishers Weekly


• “Highly Recommended” – Library Journal

  • “Best Original Work” -Audie Awards Finalist
  • “Bestseller” – Amazon.com
  • “…a gentle journey,floating worries and stress away.” -The Los Angeles Times
  • “Superb relaxation narration…” -The American Pain Society, John D. Loeser, MD
  • “Excellent…very effective.” -Strang Cancer Prevention Center, Daniel G, Miller, MD, President
  • “Peaceful imagery guides listeners into a calm, meditative state…” -Weight Watchers Magazine


More Honors & Critical Acclaim

Thoughtful, Affordable Holiday Gift of Peace in Stressful Times

Your Present: A Half-Hour of Peace, 2nd Edition Revised & Expanded is the uniquely thoughtful, cost-effective ‘Present’ for family and friends, devoted teachers, doctors, nurses and caregivers, essential workers, stressed-out students, co-workers… (and You.) Beautifully packaged for gift-giving, each cover also bears the gold “Best Audios Award” seal (Publishers Weekly.) Just tie a ribbon around it, and you’re good-to-go.

About the Author:

Award-winning stress-relief expert Susie Mantell is the author of Your Present: A Half-Hour of Peace, 2nd Edition Revised and Expanded. Her techniques have appeared on NBC, ABC, CBS TV, in The Los Angeles Times, Town & Country, Weight Watchers, Cosmopolitan. Clients and listeners include The Mayo Clinic, The Betty Ford Center, The Coca-Cola Company, Verizon, Memorial Sloan-Kettering and renowned Canyon Ranch Health Resorts. Also a pop songwriter, Mantell’s work has been heard Off-Broadway, at Carnegie Hall’s Weill Recital Hall, in TV and film. More About Susie Mantell at https://relaxintuit.com

Follow @Relaxintuit Stress-Relief on Facebook & Twitter for Daily Stress Relief

Share article on social media or email:



Dr. Kevin Hogan is Now Offering Night Guards for Stress-Related Teeth Grinding in Mt. Pleasant, SC


Dr. Kevin Hogan, Dentist in Mt. Pleasant, SC.

Dr. Kevin Hogan Provides Night Guards for Teeth Grinding in Mt. Pleasant, SC

In order to keep his Mt. Pleasant community in optimum health, Dr. Hogan is nipping the long-term effects of teeth grinding in the bud.

Dr. Kevin Hogan, dentist at Smiles by Hogan, offers convenient treatment for bruxism, or teeth grinding, in Mt. Pleasant, SC to those noticing an increase in their teeth grinding due to pandemic-related stress. Research shows that oral health affects the body’s overall health, and as a result, no oral health condition should be overlooked, especially amid the COVID-19 outbreak. To help improve the health of his community, Dr. Hogan is offering mouth guards for bruxism to patients with or without a referral.

A recent study conducted by the American Dental Association (ADA) reports that a majority of dentists are seeing a rise in stress-related oral health conditions since the onset of the COVID-19 pandemic. These conditions include caries (cavities), symptoms of TMJ disorder, teeth grinding, and chipped and cracked teeth. This research shows the interconnectedness of the mind, mouth, and body as a whole.

When a person experiences stress, pandemic related or not, the risk of bruxism is heightened. When teeth grinding occurs, the person is at a greater risk of chipped or cracked teeth. This can then lead to tooth decay and gum disease, and research shows that decay and disease in the mouth has systemic effects on the body as a whole, including a weakened immune system, respiratory disease, rheumatoid arthritis, and stroke.

In order to keep his Mt. Pleasant community in optimum health, Dr. Hogan is nipping the long-term effects of teeth grinding in the bud. He is helping patients treat this condition with customized nightguards. In just one appointment, Dr. Hogan can diagnose patients and fit them for mouth guards that are designed to comfortably fit within the mouth. These mouth guards will not only reduce teeth grinding, but they can help relieve pain experienced from TMJ disorder as well. Dr. Hogan recommends that patients seek treatment at the first sign of bruxism so that they can work together to prevent the serious side effects before they start.

Dr. Hogan and the team at Smiles by Hogan are passionate about the health of their community. They are also implementing efforts into their daily work to help stop the spread of COVID-19. Dr. Hogan offers soothing IV sedation for each of his treatments. IV sedation helps relieve the anxiety of patients receiving care. It also allows Dr. Hogan to complete multiple treatments in one appointment for patients who need extensive care. Smiles by Hogan strictly follows the guidelines of the CDC, OSHA, and the ADA in regards to pandemic related protocol.

Individuals experiencing teeth grinding in Mt. Pleasant, SC can connect with Dr. Hogan for comfortable, customized mouth guards. To schedule an appointment, visit http://www.smilesbyhogan.com or call 843-216-0908.

About the Dentist

Dr. Kevin Hogan is a general dentist providing individualized care for patients in Mt. Pleasant, SC. Dr. Hogan is a graduate of the Indiana University School of Dentistry and has completed hundreds of hours of continuing education courses to stay contemporary with the latest dental technologies. In addition, he has also completed coursework with the Dental Organization for Conscious Sedation and has lectured at the University of North Carolina, Emory University, the Saginaw Valley University and AUA-American University of Antigua on head and neck anatomy and oral pathology. Dr. Hogan is a member of the American Dental Association, International College of Cranio-Mandibular Orthopedics, Academy of Laser Dentistry, International Association of Physiologic Aesthetics, Institute for Advanced Laser Dentistry, DOCS (the Dental Organization for Conscious Sedation), International Congress of Oral Implantologists and the South Carolina Dental Association. He is also a past member of the American Straight Wire Orthodontic Association, Maxillofacial Orthopedic Growth and Development, the American Academy of Pediatric Dentistry and the Functional Orthodontic Society. He and his team are dedicated to providing exceptional oral care to patients through personalized treatment plans. To learn more about the services offered by Dr. Hogan, please visit his website at http://www.smilesbyhogan.com or call 843-216-0908.

Share article on social media or email:

Kemp Proteins Enter Strategic Partnership for Commercialization of ArtiaBio Technology Platform for Stable Cell Line Development


News Image

“The addition of a proprietary technology for Stable Cell Line Development represents an important milestone and reflects our commitment to growing our company with high-quality bioservices technologies.” – Michael Keefe, CEO, Kemp Proteins

Kemp Proteins LLC, a leading provider of gene-to-protein, and monoclonal antibody development services, today announced that the company signed Strategic Partnership and Material Transfer Agreements with ArtiaBio Inc, a company specialized on the development of biopharmaceuticals, parental cell lines and highly productive expression vectors. The agreements demonstrate Kemp’s commitment to building a broad complement of bioservices focused on providing biopharmaceutical and diagnostic clients with world-class protein related development services.

Under the Agreements Kemp Proteins will gain access to ArtiaBio proprietary parental cell and vector technology for development of highly productive cell lines and cost effective, rapid manufacturing processes. ArtiaBio has the experience and history of developing highly productive recombinant cell lines and media for cGMP-ready manufacturing processes and will transfer its own cell lines, vectors and technical know-how to enable Kemp Proteins to consistently provide cell development services under ISO quality systems to meet client requirements. The cell lines developed using the ArtiaBio technology will not be royalty bearing and no license fee is applied on success, a distinct delineation between Kemp Proteins and other cell line development companies using their own proprietary technology.

“Since Six.02 Bioservices purchased Kemp in 2019, it has been our goal to develop the company into so much more than a world class gene-protein service company. Building out the hybridoma development facility and now the Stable Cell Line Development Service all under our ISO Quality System, demonstrates a continuing successful implementation of our strategy plan,” said Michael Keefe, CEO for Kemp Proteins. “The addition of a proprietary technology for Stable Cell Line Development represents an important milestone and reflects our commitment to growing our company with high-quality bioservices technologies.”

Sadettin Ozturk, President and CEO of ArtiaBio commented, “The Agreements with Kemp Proteins represent a strategic direction for ArtiaBio as the company becomes more focused on developing our own biopharmaceuticals while providing services to the industry. Working with the team at Kemp we will ensure that our highly productive, proprietary vectors and cell lines will enable others to develop stable cell lines expressing proteins of interest. This technology has been used to develop a number of novel and biosimilar processes and I am sure others will benefit from using this technology in their own programs.”

About Kemp Proteins (http://www.kempproteins.com)

Kemp Proteins (formerly Kempbio) is a leading provider of gene-to-protein, hybridoma and cell line development services. For more than 20 years, Kemp’s team of protein problem-solvers has delivered best-in-class services that optimize productivity and mitigate risk for life sciences innovators developing protein-based products, including human and veterinary diagnostics, biopharmaceuticals, and vaccines. Kemp Proteins is a Six.02 Bioservices member company.

About ArtiaBio (http://www.artiabio.com)

ArtiaBio is a dynamic company focused on the development of biopharmaceuticals. The advanced technology in cell line and process development combined with the utilization of advanced bioprocess technology enables development of highly effective manufacturing processes that can provide the biotechnology-based drugs at an affordable price. The company has experience and expertise in a broad range of product development, including monoclonal antibodies, blood coagulation factors, therapeutic enzymes, and fusion proteins.

Share article on social media or email:

Potential Solution for Ultra-Cold COVID-19 Vaccine Distribution


Cryogel Insulation

Cryogel Insulation

“Cryogel® insulation allows container manufacturers to extend the required temperature stability of COVID-19 vaccines longer than the 5 days dry ice and traditional insulation materials provide,” states Todd Hudson, Director of Sales.

Pacor, Inc., (https://www.pacorinc.com) a leading fabricator of insulation solutions for OEM and Industrial Applications, is proud to announce that Cryogel® can extend the sub ambient temperature stability substantially longer than dry ice and traditional insulation materials.

The recent news announcements of the efficacy of Covid-19 vaccines are very encouraging. One particular vaccine, however, requires Ultra-Cold (-70 C) temperatures for transport and storage.

If your company manufactures containers, boxes or coolers for storing or transporting medical supplies like vaccines, the news also made clear that is a large challenge for small or rural medical clinics and facilities.

These facilities have limited resources, personnel and access to dry ice, especially during a dry ice supply shortage and increased competition to acquire the scant amount available.                                                                                                    

How does your company produce a storage container that can stay at -70 C degrees for significant periods of time?

How can your company’s containers assist these remote medical facilities that need to replenish dry ice every 5 days, in order to maintain this temperature and not threaten viability of the vaccine?

Pacor has a solution for you: Cryogel insulation. Cryogel® is made specifically for sub ambient and cryogenic applications. Cryogel® can extend the sub ambient temperature stability substantially longer than the 5 days expected from using dry ice with traditional insulation materials

Pacor can custom fabricate Cryogel® to fit any type of container, box or cooler.

Share article on social media or email:

COVID-19 Pandemic Accelerates Opioid Overdose Deaths


Waismann Method® Opioid Treatment Specialists and Rapid Detox Center

Waismann Method® Opioid Treatment Specialists and Rapid Detox Center

A comprehensive inpatient medical evaluation, successful medical detox, and an accurate emotional assessment with an individualized plan are the best components to support people in maintaining a healthy journey.

As of December 7, 2020, the United States reports more than 14.7 million confirmed cases of COVID-19 and 282,345 deaths due to the virus. However, the true magnitude of the pandemic is much greater. These death tolls do not include individuals who die due to lack of medical resources, and overburdened medical system, suicide, or mental health-related illnesses such as addiction.

The new report, published in JAMA Psychiatry, included data from the National Emergency Medical Services (EMS) Information System. This system includes information from more than 10,000 EMS agencies across 47 states, providing a comprehensive view of medical events in the United States. The report showed overdose-related cardiac arrests rising sharply in April 2020. By May 4, rates were more than double the baseline from 2018 and 2019. Overdose-related cardiac arrests decreased slightly in the summer months but remained 53.7% above baseline by July 27 and 48.5% above baseline by August 1.

The report also highlighted the relationship between mobility and overdose-related cardiac arrest. As mobility decreased sharply under stay-at-home orders, cardiac arrests rose. The researchers at the University of California-Los Angeles who authored the report speculate that the increase in overdose-related cardiac arrests may be due to more people using substances alone, increased toxicity of the drug supply, and reduced access to treatment. Combined, these factors make each overdose incident more deadly.

In response to the alarming report from JAMA Psychiatry, the Waismann Method Medical Group calls for mental health to be placed at the center of the conversation about the opioid crisis and COVID-19 pandemic. Dr. Michael H. Lowenstein, Director of the Waismann Method Medical Group, stated, “This report highlights what so many of us on the front lines of this crisis already know: the COVID-19 pandemic is making the opioid crisis worse. Mental health is deteriorating, and social isolation is putting people in risky situations. It’s time to treat addiction and mental health problems as seriously as COVID-19.”

Bold Action Needed to Combat the Twin Epidemics: COVID-19 and the Opioid Crisis

Before the COVID-19 pandemic, the United States was in the midst of an unprecedented opioid epidemic. This left a large portion of the population medically, socially, and psychologically vulnerable. The sharp increase in opioid-related overdose deaths since March 2020 points to the need for immediate action to address these twin crises.

COVID-19 infection contributes to respiratory frailty, which can be deadly for individuals suffering from opioid addiction. Mental health is an equally large concern. Social distancing and other safety measures are critical in reducing the spread of the virus. However, they also contribute to isolation, loneliness, and worsening of mental health symptoms. By late June 2020, 40% of Americans were dealing with substance abuse or mental health problems. Younger adults, essential workers, unpaid adult caregivers, and racial/ethnic minorities are disproportionately affected.

Opioid use disorder does not occur in a vacuum. It is driven by depression, anxiety, trauma, isolation, and other serious mental health problems. Only by treating these underlying mental health symptoms can we help people achieve long-lasting sobriety. Waismann Method Medical Group calls on public health officials to expand funding for education, mental health treatment, and life-saving medical care, including a medical detox. We urgently need to provide mental health and medical treatment to the vulnerable people who need it most.

About Waismann Method®

Waismann Method® has more than two decades of experience providing top-quality medical care for those suffering from Opioid Use Disorder (OUD). The center is internationally recognized for its hospital-based medically assisted opioid treatment, rapid detox protocol, and exclusive Domus Retreat for post-detox aftercare. The program is located exclusively in Southern California, where thousands of patients from all over the world have been successfully treated.

Clare Waismann SUDCC, RAS, founded the center in 1998. Its goal was and still is to continue providing the most effective, safe, and comfortable medically assisted opioid detoxification. A treatment option that helps individuals achieve an opioid-free state which allows them to be emotionally present for a more accurate psychological assessment and adherence to the indicated therapy. “A comprehensive inpatient medical evaluation, successful medical detox, and an accurate emotional assessment with an individualized plan are the best components to support people in maintaining a healthy journey,” Clare Waismann.

Waismann Method® and Domus Retreat, together, provide people a scientific and individualized approach to patient care, featuring a multidisciplinary team to ensure safety, comfort, and success.

Find out more about Waismann Method® at https://www.opiates.com.

LinkedIn

Facebook

Twitter

Share article on social media or email:



Hackensack Meridian Health and Visikol Partner to Evaluate Tuberculosis Treatments Using Visikol’s Multiplex Imaging Tools


Our novel multiplex approach allows Visikol to visualize ten or more targets simultaneously while also providing clients with custom designed and validated panels

Tuberculosis (TB) is still one of the top ten leading causes of death globally. Although TB is both preventable and curable, in the last year alone there were approximately 10 million worldwide cases, of which 1.4 million people died. Yet, in the United States and many developed countries the risk of TB exposure is low as 95% of cases are in developing countries. The World Health Organization noted that an estimated 60 million lives have been saved by preventative diagnosis and treatment. However, 6 months of daily treatment with multiple antibiotics are required to cure even the most common form of TB, and the COVID pandemic has a devastating predicted impact on TB burden and deaths worldwide, stressing the critical need for new safe and effective drug regimens.

Visikol and Hackensack Meridian Health (HMH) have partnered to evaluate TB antibiotics through a grant from the Bill & Melinda Gates Foundation. The project will analyze old and new drugs’ ability to penetrate into granulomas – the primary site of TB infection in the lungs – and the multiple cell types involved in the interaction with the drugs. Current data from Dr. Véronique Dartois, an HMH researcher and the study’s principal investigator, indicates that drugs differentially penetrate TB granulomas. Understanding the co-localization of drugs and immune cells will be important to determine if drugs can access and kill persistent Mycobacterium tuberculosis (Mtb) populations. Mtb is the bacterium that attacks the lungs and causes inflammation and lung tissue destruction. Ultimately, these insights will guide the TB Drug Accelerator and TB drug discovery projects which can potentially lead to more efficacious treatments.

To thoroughly evaluate the effects of drugs and their interactions with the surrounding tissue, Visikol will leverage its proprietary fluorescent multiplexed immunohistochemistry approach combined with MALDI mass spectrometry imaging. This multi-modal approach will be used to automate the quantitative investigation of drug distribution into TB lung lesions. Visikol’s highly multiplexed imaging approach relies on simultaneous and sequential detection of multiple cellular markers, using multicolor fluorescent immunohistochemistry combined with automated multispectral slide imaging, and advanced image analysis software to identify and determine the spatial distribution of immune cells.

“Our novel multiplex approach allows Visikol to visualize ten or more targets simultaneously while also providing clients with custom designed and validated panels in combination with high resolution whole slide imaging, image analysis and comprehensive reporting,” noted Visikol CSO Tom Villani, Ph.D.

The partnership with Hackensack comes as HMH Hospitals are again recognized as leaders in not only New Jersey but across the country. Of the health care systems in New Jersey, HMH is the largest and has the most top-ranked hospitals. In the time of COVID-19 HMH has continually proven itself to be a leader on the front lines combatting the virus and helping patients towards recovery.

“Hackensack has continually been recognized as not only a top hospital and healthcare system, but also as a top research organization. The opportunity to work alongside such a talented group of scientists with support from the Gates Foundation is an exciting opportunity for us,” mentioned Visikol CEO Michael Johnson, Ph.D.

The data from this study will provide beneficial knowledge to researchers in determining what types of drugs are most effective in treating TB. Visikol’s approach to multiplex imaging will provide important insights in the TB drug discovery process that are both timely and data driven.

About Visikol Incorporated

Visikol is a CRO that is focused on accelerating drug discovery and development through the use of its imaging, digital pathology and advanced cell culture assay services. The company provides end-to-end preclinical services that include both 2D and 3D in vitro models and assays, 3D whole mount tissue imaging, multiplex imaging, high content imaging, digital pathology and custom drug discovery solutions. Visikol’s expertise is in transforming tissues and cells into large image-based data sets that can be mined for actionable insights such that pharmaceutical and biotech companies can make more quantitative and informed decision during the drug development process. Additionally, Visikol manufactures and sells a suite of tissue clearing reagents and 3D immuno-labeling kits. These products allow researchers to easily and rapidly image whole tissues and 3D cell culture models in 3D instead of traditional 2D sectioning. For more information about Visikol or its services, please visit http://www.visikol.com.

Share article on social media or email: